News and Updates

What’s Happening? In an exciting update for the type 1 diabetes (T1D) community, Tzield—the first disease-modifying therapy approved by the FDA to delay progression of stage 2 T1D—has now been approved by the FDA for use in stage 3 T1D. People aged 8-17 with stage 3 T1D will soon be able to get Tzield in clinics (with a prescription) if […]

Breakthrough T1D was on site in New Orleans, LA from June 5-8 for the American Diabetes Association’s (ADA) 86th Scientific Sessions. Check out all of our coverage below, including type 1 diabetes (T1D) advances across all our mission priority areas and several Breakthrough T1D-funded researchers and staff driving progress forward. In case you missed it, […]

Breakthrough T1D is here to answer all of your questions about islet cell therapies, from the research lab to real-world treatments.

ADA’s 86th Scientific Sessions This event is one of the largest diabetes conferences in the world, bringing together over 11,000 attendees to share and learn about cutting-edge research and advancements toward cures. Each year, Breakthrough T1D-funded researchers highlight their work, demonstrating the progress we’re making toward achieving our mission. Leading experts will present over 100 […]

New data from a Breakthrough T1D–funded islet cell transplant trial shows all 12 participants are off external insulin using tegoprubart.

ADA’s 86th Scientific Sessions This event is one of the largest diabetes conferences in the world, bringing together over 11,000 attendees to share and learn about cutting-edge research and advancements toward cures. Each year, Breakthrough T1D-funded researchers highlight their work, demonstrating the progress we’re making toward achieving our mission. Leading experts will present over 100 […]

Breakthrough T1D is deeply saddened at the passing of William V. Tamborlane, M.D. Dr. Tamborlane was a tireless champion for the type 1 diabetes (T1D) community, a pioneering clinical scientist, dedicated physician, and longtime Breakthrough T1D partner, grantee, reviewer, advisor, and friend. “Bill Tamborlane was a giant in our field, and he will be terribly […]

Breakthrough T1D's guide to summer with type 1 diabetes provides tips to help you stay safe and healthy.

It’s critical that in an emergency situation, people with T1D are prepared! Depending on where you live, common summer emergencies may include heat waves, hurricanes, wildfires, and power outages—sometimes all at once. Keeping Insulin Cool During a summer emergency, it’s important to keep your insulin cool as, like any other protein, it risks being damaged […]

Afrezza, a rapid-acting, inhaled mealtime insulin, has been approved by the FDA for use in children and adolescents ages 6+ with T1D.